You are here
posted on December 16, 2014
Two MSI Principal Investigators, Associate Professor Reuben Harris (Biochemistry, Molecular Biology, and Biophysics) and Assistant Professor Daniel Harki (Medicinal Chemistry), have founded a start-up company that will create drug therapies for cancer treatment. ApoGen Biotechnologies, Inc. is developing a new class of drugs based on blocking the activity of the protein APOBEC, which is found in many cancer tumors. Both Professors Harris and Harki use MSI to support their research into APOBEC-family proteins.
An article about ApoGen Biotechnologies appeared recently on the OVPR’s Inquiry blog.
posted on December 10, 2014
Principal Investigator Dan Knights, an assistant professor in the Department of Computer Science and Engineering (College of Science and Engineering), was featured recently in an article that appeared in the [St. Paul, Minnesota] Pioneer Press. The article discusses his research into the human microbiome, for which he uses MSI. You can read the article on the TwinCities.com website.
posted on December 9, 2014
MSI Principal Investigator Samuel Myers, Jr., a professor at the Hubert H. Humphrey School of Public Affairs, is the latest recipient of the Samuel Z. Westerfield, Jr. Award from the National Economic Association (NEA). The award will be presented at the organization’s annual meeting in January 2015. The Westerfield Award is the NEA’s highest honor.
Professor Myers specializes in research concerning social policies and their impact on the socially disadvantaged. He uses MSI to support his research, including a project to study mortgage-lending discrimination and a study of responsible banking in the Twin Cities. See more on the Humphrey School’s website.
posted on December 8, 2014
The Office of the Vice President for Research (OVPR) has published a list of patents that have been awarded to University researchers during the several months. Several MSI Principal Investigators are on this list. The complete list can be found on the OVPR's Inquiry blog post, "Patent roll call, fall 2014."
MSI PIs are shown below in bold. The PIs' group pages are linked from their names. Clicking on the Project Title on the PI page will take you to an abstract of the researchers' project(s) at MSI.
Ramesh Nataragan, Arindam Banerjee (Computer Science and Engineering), and Hanhuai Shan:
Phillipe Buhlmann (Chemistry) and Paul Boswell:
Curtis Corum, Michael Garwood (Center for Magnetic Resonance Research), Steen Moeller, Djaudat Idiyatullin, and Ryan Chamberlain:
Curtis Corum, Djaudat Idiyatullin, Steen Moeller, and Michael Garwood (Center for Magnetic Resonance Research):
Apostolos Georgopoulos (Neuroscience)
Georgios Giannakis (Director, Digital Technology Center; Electrical and Computer Engineering) and Xiaoli Ma:
Nathan Lindquist, Wade Luhman, Russell Holmes, and Sang-Hyun Oh (Electrical and Computer Engineering):
Patrick Schlievert and Marnie Peterson (Pharmacy):
posted on December 5, 2014
Several MSI Principal Investigators are involved in an interdisciplinary project that is evaluating how introducing beneficial bacteria into diabetes patients’ intestines might improve their insulin sensitivity. Insulin sends glucose from the blood into other cells in the body; people with diabetes are unable to properly regulate their blood sugar.
MSI PIs on the team include Professor Michael Sadowsky (Director, BioTechnology Institute; Soil, Water, and Climate), Associate Professor Douglas Mashek (Food Science and Nutrition), Professor Kelvin Lim (Psychiatry), and Professor David Bernlohr (Head, Biochemistry, Molecular Biology, and Biophysics). The lead researcher is Professor Alexander Khoruts (Medicine), a leader in the field of microbiota transplants.
An article about this project can be read on the OVPR’s Inquiry blog.